AAAAAA
Results: 1-25/65
Authors:
DAVIS BR
SAITTA FP
BAUER G
BUNNELL BA
MORGAN RA
SCHWARTZ DH
Citation: Br. Davis et al., TARGETED TRANSDUCTION OF CD34(-EXPRESSING RETROVIRUS YIELDS PARTIAL ANTI-HIV PROTECTION OF PROGENY MACROPHAGES() CELLS BY TRANSDOMINANT NEGATIVE REV), Human gene therapy, 9(8), 1998, pp. 1197-1207
Authors:
ARNOLD JMO
DAVIS BR
NASH DT
INSUL W
LEWIS S
KOHN RM
GLASSER SP
BELEW KM
KIMMEL B
SACKS FM
Citation: Jmo. Arnold et al., LIPID-LEVELS, ADHERENCE TO MEDICATION, BASE-LINE CHARACTERISTICS IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 89-89
Authors:
DAVIS BR
SANDOR GKB
Citation: Br. Davis et Gkb. Sandor, USE OF FIBRIN GLUE IN MAXILLOFACIAL SURGERY, Journal of otolaryngology, 27(2), 1998, pp. 107-112
Authors:
FULLER LM
MIRZA NQ
PALMER JL
DAVIS BR
HA CS
RODRIGUEZ MA
HAGEMEISTER FB
CABANILLAS F
MCLAUGHLIN P
BUTLER JJ
NORTH LB
MARTIN RG
Citation: Lm. Fuller et al., HODGKINS-DISEASE - CORRELATION OF CLINICAL CHARACTERISTICS WITH PROBABILITIES FOR NEGATIVE LYMPHANGIOGRAM VS. NEGATIVE LAPAROTOMY FINDINGS IN PATIENTS WITH STAGE-I SUPRADIAPHRAGMATIC PRESENTATIONS VS. THOSE INPATIENTS WITH STAGE-II, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 377-386
Authors:
YAO A
MARX JC
LIU H
DAVIS BR
Citation: A. Yao et al., ELECTROPORATION-MEDIATED GENE DELIVERY TO PRIMITIVE HUMAN HEMATOPOIETIC-CELLS, Experimental hematology, 26(8), 1998, pp. 276-276
Authors:
NWACHUKU CE
CUTLER JA
PAYNE GH
PROSCHAN MA
FORD CE
DAVIS BR
PRESSEL SL
HAWKINS CM
Citation: Ce. Nwachuku et al., REGIONAL DIFFERENCES IN ATTAINMENT OF GOAL BLOOD-PRESSURE (BP) AMONG TREATED HYPERTENSIVE PATIENTS IN THE UNITED-STATES, Journal of hypertension, 16, 1998, pp. 96-96
Authors:
DAVIS BR
VOGT T
FROST PH
BURLANDO A
COHEN J
WILSON A
BRASS LM
FRISHMAN W
PRICE T
STAMLER J
Citation: Br. Davis et al., RISK-FACTORS FOR STROKE AND TYPE OF STROKE IN PERSONS WITH ISOLATED SYSTOLIC HYPERTENSION, Stroke, 29(7), 1998, pp. 1333-1340
Authors:
PLEHN JF
ROULEAU JL
PFEFFER MA
DAVIS BR
BERNSTEIN V
CUDDY TE
MOYE LA
PILLER LB
RUTHERFORD JD
SIMPSON LM
BRAUNWALD E
SACKS FM
Citation: Jf. Plehn et al., REDUCTION OF STROKE INCIDENCE FOLLOWING MYOCARDIAL-INFARCTION WITH PRAVASTATIN - THE CARE STUDY, Stroke, 29(1), 1998, pp. 70-70
Authors:
ARNOLD JMO
DAVIS BR
NASH DT
INSULL W
LEWIS S
KOHN RM
GLASSER SP
BELEW KM
KIMMEL B
ZIMBALDI NC
SACKS FM
Citation: Jmo. Arnold et al., INFLUENCE OF PATIENT ADHERENCE TO TREATMENT BY PILL COUNT AND CLINICAL OUTCOMES IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY, Circulation, 98(17), 1998, pp. 4258-4258
Authors:
SACKS FM
MOYE LA
DAVIS BR
COLE TG
ROULEAU JL
NASH DT
PFEFFER MA
BRAUNWALD E
Citation: Fm. Sacks et al., RELATIONSHIP BETWEEN PLASMA LDL CONCENTRATIONS DURING TREATMENT WITH PRAVASTATIN AND RECURRENT CORONARY EVENTS IN THE CHOLESTEROL AND RECURRENT EVENTS TRIAL, Circulation, 97(15), 1998, pp. 1446-1452
Authors:
SAVAGE PJ
PRESSEL SL
CURB JD
SCHRON EB
APPLEGATE WB
BLACK HR
COHEN J
DAVIS BR
FROST P
SMITH W
GONZALEZ N
GUTHRIE GP
OBERMAN A
RUTAN G
PROBSTFIELD JL
STAMLER J
Citation: Pj. Savage et al., INFLUENCE OF LONG-TERM, LOW-DOSE, DIURETIC-BASED, ANTIHYPERTENSIVE THERAPY ON GLUCOSE, LIPID, URIC-ACID, AND POTASSIUM LEVELS IN OLDER MEN AND WOMEN WITH ISOLATED SYSTOLIC HYPERTENSION - THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM, Archives of internal medicine, 158(7), 1998, pp. 741-751
Authors:
LEWIS SJ
MOYE LA
SACKS FM
JOHNSTONE DE
TIMMIS G
MITCHELL J
LIMACHER M
KELL S
GLASSER SP
GRANT J
DAVIS BR
PFEFFER MA
BRAUNWALD E
Citation: Sj. Lewis et al., EFFECT OF PRAVASTATIN ON CARDIOVASCULAR EVENTS IN OLDER PATIENTS WITHMYOCARDIAL-INFARCTION AND CHOLESTEROL LEVELS IN THE AVERAGE RANGE - RESULTS OF THE CHOLESTEROL AND RECURRENT EVENTS (CARE) TRIAL, Annals of internal medicine, 129(9), 1998, pp. 681
Authors:
HAGER WD
DAVIS BR
RIBA A
MOYE LA
WUN CC
ROULEAU JL
LAMAS GA
PFEFFER MA
Citation: Wd. Hager et al., ABSENCE OF A DELETERIOUS EFFECT OF CALCIUM-CHANNEL BLOCKERS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - THESAVE STUDY EXPERIENCE, The American heart journal, 135(3), 1998, pp. 406-413
Authors:
KOSTIS JB
DAVIS BR
CUTLER J
GRIMM RH
BERGE KG
COHEN JD
LACY CR
PERRY HM
BLAUFOX MD
WASSERTHEILSMOLLER S
BLACK HR
SCHRON E
BERKSON DM
CURB JD
SMITH WM
MCDONALD R
APPLEGATE WB
Citation: Jb. Kostis et al., PREVENTION OF HEART-FAILURE BY ANTIHYPERTENSIVE DRUG-TREATMENT IN OLDER PERSONS WITH ISOLATED SYSTOLIC HYPERTENSION, JAMA, the journal of the American Medical Association, 278(3), 1997, pp. 212-216
THE INFLUENCE ON CORONARY EVENTS OF LIPID THERAPY DURING TREATMENT WITH PRAVASTATIN - THE CARE TRIAL
Authors:
SACKS FM
MOYE LA
DAVIS BR
ROULEAU JL
PFEFFER MA
COLE TG
BRAUNWALD E
Citation: Fm. Sacks et al., THE INFLUENCE ON CORONARY EVENTS OF LIPID THERAPY DURING TREATMENT WITH PRAVASTATIN - THE CARE TRIAL, Circulation, 96(8), 1997, pp. 358-358
Authors:
GRIMM RH
DAVIS BR
FORD C
ALDERMAN MH
BLACK HR
CUSHMAN WC
DEQUATTRO V
PAPADEMETRIOU V
Citation: Rh. Grimm et al., THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT) - THE LARGEST HYPERTENSION STUDY EVER UNDERTAKEN -BASE-LINE CHARACTERISTICS, Circulation, 96(8), 1997, pp. 1542-1542
Authors:
DAVIS BR
HINDS MG
Citation: Br. Davis et Mg. Hinds, CLEMMENSEN REDUCTION .12. THE SYNTHESIS AND ACIDOLYSIS OF SOME DIARYL-SUBSTITUTED CYCLOPROPANE-1,2-DIOLS - THE POSSIBLE INVOLVEMENT OF A CYCLOPROPYL CATION, Australian Journal of Chemistry, 50(4), 1997, pp. 309-319
Authors:
WHELTON PK
WILLIAMSON JD
LOUIS GT
DAVIS BR
CUTLER JA
Citation: Pk. Whelton et al., EXPERIMENTAL APPROACHES TO DETERMINING THE CHOICE OF FIRST-STEP THERAPY FOR PATIENTS WITH HYPERTENSION, Clinical and experimental hypertension, 18(3-4), 1996, pp. 569-579
Authors:
DAVIS BR
CUTLER JA
GORDON DJ
FURBERG CD
WRIGHT JT
CUSHMAN WC
GRIMM RH
LAROSA J
WHELTON PK
PERRY HM
ALDERMAN MH
FORD CE
OPARIL S
FRANCIS C
PROSCHAN M
PRESSEL S
BLACK HR
HAWKINS CM
Citation: Br. Davis et al., RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT), American journal of hypertension, 9(4), 1996, pp. 342-360
Authors:
MOYE LA
DAVIS BR
SACKS F
COLE T
BROWN L
HAWKINS CM
Citation: La. Moye et al., DECISION RULES FOR PREDICTING FUTURE LIPID VALUES IN SCREENING FOR A CHOLESTEROL REDUCTION CLINICAL-TRIAL, Controlled clinical trials, 17(6), 1996, pp. 536-546
Authors:
QUINN GE
DOBSON V
BARR CC
DAVIS BR
PALMER EA
ROBERTSON J
SUMMERS CG
TRESE MT
TUNG B
Citation: Ge. Quinn et al., VISUAL-ACUITY OF EYES AFTER VITRECTOMY FOR ROP - REPLY, Ophthalmology, 103(9), 1996, pp. 1332-1332
Authors:
QUINN GE
DOBSON V
BARR CC
DAVIS BR
PALMER EA
ROBERTSON J
SUMMERS CG
TRESE MT
TUNG B
Citation: Ge. Quinn et al., VISUAL-ACUITY OF EYES AFTER VITRECTOMY FOR RETINOPATHY OF PREMATURITY- FOLLOW-UP AT 5 1 2 YEARS/, Ophthalmology, 103(4), 1996, pp. 595-600
Authors:
BLAUFOX MD
MIDDLETON ML
BONGIOVANNI J
DAVIS BR
Citation: Md. Blaufox et al., COST EFFICACY OF THE DIAGNOSIS AND THERAPY OF RENOVASCULAR HYPERTENSION, The Journal of nuclear medicine, 37(1), 1996, pp. 171-177
Authors:
QUINN GE
DOBSON V
BARR CC
DAVIS BR
PALMER EA
ROBERTSON J
SUMMERS CG
TRESE MT
TUNG B
Citation: Ge. Quinn et al., VISUAL-ACUITY OF EYES AFTER VITRECTOMY FOR ROP - FOLLOW-UP AT 5-1 2 YEARS/, Investigative ophthalmology & visual science, 37(3), 1996, pp. 598-598
Authors:
CURB JD
PRESSEL SL
CUTLER JA
SAVAGE PJ
APPLEGATE WB
BLACK H
CAMEL G
DAVIS BR
FROST PH
GONZALEZ N
GUTHRIE G
OBERMAN A
RUTAN GH
STAMLER J
Citation: Jd. Curb et al., EFFECT OF DIURETIC-BASED ANTIHYPERTENSIVE TREATMENT ON CARDIOVASCULAR-DISEASE RISK IN OLDER DIABETIC-PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION, JAMA, the journal of the American Medical Association, 276(23), 1996, pp. 1886-1892